Compounded T3 and T4 tablets prepared per prescriber direction for individualized thyroid hormone care planning. Prescription required.
T3 and T4 Tablets are compounded thyroid hormone formulations prepared by HDRx according to individualized prescriber specifications, including customized strength and hormone ratios. A valid prescription from a licensed healthcare provider is required.
Triiodothyronine (T3) and thyroxine (T4) are thyroid hormones that may be incorporated into provider-directed endocrine care plans when clinically appropriate. Compounding allows prescribers to select specific T3 and T4 combinations and dosing parameters based on individualized monitoring and clinical considerations.
Tablet formulations can be prepared with customized strengths and ingredient selections to accommodate patient-specific requirements, including allergen-conscious formulations when appropriate.
HDRx collaborates with healthcare providers to prepare customized thyroid hormone formulations as part of structured endocrine care planning. Learn more about thyroid and adrenal hormone considerations on our Thyroid & Adrenal Hormones page and related discussions regarding evolving thyroid medication guidance in our article on recent FDA thyroid medication updates.
Compounded medications are not FDA-approved and are prepared to meet specific patient needs. Patients should consult their licensed healthcare provider to determine whether this formulation is appropriate for their individual endocrine care plan.
